bloodthinners

Many at risk for stroke don’t get anti-clotting drugs
Reuters
Fri, 03/17/17 - 09:25 am
stroke
atrial fibrillation
Pradaxa
Xarelto
Eliquis
bloodthinners
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
Bayer touts Xarelto strength on heels of COMPASS data
BioPharma Dive
Thu, 02/23/17 - 09:37 pm
Bayer
Xarelto
bloodthinners
Bayer's blood thinner also effective for artery disease
Yahoo/Reuters
Wed, 02/8/17 - 09:34 pm
Bayer
bloodthinners
Xarelto
peripheral artery disease
coronary artery disease
Eliquis Proving to Be a Major Growth Driver for Pfizer This Year
Market Realist
Mon, 10/24/16 - 11:42 pm
Eliquis
bloodthinners
Pfizer
Bayer's Xarelto projected to become top-selling drug in Europe by 2022
BioPharma Dive
Thu, 05/5/16 - 09:34 am
Bayer
Xarelto
bloodthinners
Europe
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Fierce Pharma Marketing
Wed, 02/3/16 - 05:30 pm
bloodthinners
Bristol-Myers Squibb
Eliquis
Xarelto
Pradaxa
Bayer
Pfizer
JNJ
Boehringer Ingelheim
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Fierce Biotech
Sat, 10/17/15 - 03:30 pm
Boehringer Ingelheim
FDA
Pradaxa
bloodthinners
Praxbind
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Thu, 10/1/15 - 05:29 pm
Pradaxa
Xarelto
Eliquis
bloodthinners
Warfarin
drug safety
JNJ
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
FDA approves expanded indication for AstraZeneca's blood thinner
Yahoo/Reuters
Thu, 09/3/15 - 06:31 pm
FDA
AstraZeneca
Brilinta
bloodthinners
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
Fierce Pharma
Tue, 09/1/15 - 06:37 pm
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Xarelto
Daiichi clot-buster wins a NICE green light, but still faces an uphill track
Fierce Biotech
Wed, 08/12/15 - 12:41 pm
Daiichi Sankyo
bloodthinners
Lixiana
edoxaban
NICE
Bayer, J&J touting Xarelto trial data to counteract Eliquis surge
Fierce Pharma Marketing
Tue, 06/30/15 - 11:30 am
Bayer
JNJ
Xarelto
clinical trial data
bloodthinners
Eliquis
Pfizer
Bristol-Myers Squibb
Should Eliquis' surge make Xarelto fans very, very afraid? Not really, analyst says
Fierce Pharma Marketing
Mon, 05/18/15 - 10:37 am
Eliquis
Xarelto
bloodthinners
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Bayer says Xarelto isn't losing U.S. market share to Eliquis
Yahoo/Reuters
Thu, 04/30/15 - 11:10 am
Bayer
Xarelto
bloodthinners
Eliquis
After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor
Fierce Biotech
Mon, 04/13/15 - 10:42 am
FDA
Medicines Company
bloodthinners
Cangrelor
The Small-Cap Biotech Stock You Should Be Watching
Motley Fool
Mon, 02/16/15 - 11:50 am
biotech
Portola
andexanet alfa
bloodthinners
Portola's drug reverses effect of J&J's blood thinner Xarelto
Yahoo/Reuters
Fri, 01/9/15 - 09:14 am
Portola Pharmaceuticals
JNJ
Xarelto
bloodthinners
andexanet alfa
FDA Approves New Oral Anticoagulant From Daiichi Sankyo
Forbes
Thu, 01/8/15 - 10:17 pm
FDA
Daiichi Sankyo
bloodthinners
Savaysa
J&J looks for Xarelto boost in real-world cost data
Fierce Pharma Marketing
Thu, 12/4/14 - 10:21 am
JNJ
Xarelto
bloodthinners

Pages